Changrong Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
22
- Portfolio
-
15
- Exits
-
8
Changrong Capital General Information
Company Description
Founded in 2007, Changrong Capital is a venture capital firm based in Xiamen, China. The firm seeks to make investments in companies operating in biomedicine, artificial intelligence, semiconductors, new energy, and education sectors.
Business Details
Website
www.xmcrcapital.cnYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 29th Floor, Fortune Center, 100 Lujiang Road
- Siming District
- Xiamen, Fujian
- China
Changrong Capital Investments (22)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Guizhou Huajin | 01-Apr-2026 | Later Stage VC | Gold Mining | Generating Revenue | ||
| Proviva Therapeutics | 01-Dec-2025 | Discovery Tools (Healthcare) | Generating Revenue | |||
| AmacaThera | 01-Jul-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Fatri | 06-Jan-2022 | General Purpose Semiconductors | Generating Revenue | |||
| Amberstone Biosciences | 03-Jan-2022 | Drug Discovery | Pre-Clinical Trials | |||
| Arthrosi Therapeutics | 15-Nov-2021 | Drug Discovery | Generating Revenue | |||
| Eubulus Biotherapeutics | 12-Oct-2021 | Biotechnology | Generating Revenue | |||
| NAKI Therapeutics | 01-Oct-2021 | Biotechnology | Generating Revenue | |||
| Anji Pharma | 28-Sep-2021 | Early Stage VC | Drug Discovery | Out of Business | ||
| Viva Vision Biotech | 09-Aug-2021 | Later Stage VC | Drug Discovery | Generating Revenue |
Changrong Capital Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Arthrosi Therapeutics | 09-Feb-2026 | Merger/Acquisition | |
| Anji Pharma | 05-Jun-2025 | ||
| Focus-X Therapeutics | 05-Dec-2022 | ||
| One-Man University | 22-Mar-2022 | ||
| ESSE IC | 14-Oct-2021 | ||
| Dogma Therapeutics | 17-Sep-2020 | Merger/Acquisition | |
| Guangzhou Ambition (LBP) Pharmaceutical Technology | 23-Dec-2016 | Merger/Acquisition |
Changrong Capital Investments by Industry, Year, and Region
Changrong Capital Co-Investors (10)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Bojiang Capital | 1 |
|
|
||
| HSG (Hong Kong) |
|
|
|||
| Haitong Fortis Private Equity |
|
|
|||
| OrbiMed |
|
|
|||
| Sinovation Ventures |
|
|
Changrong Capital FAQs
-
What is Changrong Capital?
Founded in 2007, Changrong Capital is a venture capital firm based in Xiamen, China.
-
When was Changrong Capital founded?
Changrong Capital was founded in 2007.
-
Where is Changrong Capital headquartered?
Changrong Capital is headquartered in Xiamen, China.
-
How many investments has Changrong Capital made?
Changrong Capital has made 22 investments.
-
What has Changrong Capital invested in?
Changrong Capital has made numerous investments in companies like Guizhou Huajin, Proviva Therapeutics, and AmacaThera within the Gold Mining, Discovery Tools (Healthcare), and Drug Discovery industries.
-
What has Changrong Capital invested in recently?
Changrong Capital's latest investment was on 01-Apr-2026 in Guizhou Huajin, a company within the Gold Mining industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process